Allogene Therapeutics, Inc.
ALLOCIK 0001737287 · Every Form 4 filed by insiders at this issuer.
Filings
9
Latest Mar 18, 2024
Unique insiders
6
Showing
9 of 9
Page 1
Top insiders
Most active reporters at Allogene Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Chang David D | OfficerDirector | 2 |
| Parker Geoffrey M. | Officer | 2 |
| Roberts Zachary | Officer | 2 |
| Belldegrun Arie | Director | 1 |
| Douglas Earl Martin | Officer | 1 |
| MOORE TIMOTHY L. | Officer | 1 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 18, 2024 | Chang David D President and CEO · Director | F | 53,393 | $4.33 | $231,192 | |
| Mar 6, 2024 | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | P | 190 | $3.595 | $683 | |
| Jan 31, 2024 | Chang David D President and CEO · Director | A | 317,800 | $0.00 | $0 | |
| Jan 31, 2024 | Roberts Zachary EVP of R&D | A | 140,000 | $0.00 | $0 | |
| Jan 31, 2024 | Belldegrun Arie Director | A | 211,973 | $0.00 | $0 | |
| Jan 31, 2024 | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | A | 29,400 | $0.00 | $0 | |
| Jan 31, 2024 | Douglas Earl Martin SVP, General Counsel | A | 41,800 | $0.00 | $0 | |
| Jan 31, 2024 | MOORE TIMOTHY L. Chief Technical Officer | A | 96,600 | $0.00 | $0 | |
| Jan 24, 2024 | Roberts Zachary EVP of R&D | F | 24,690 | $3.1744 | $78,376 |
Showing 1–9 of 9
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.